Apollo Endosurgery, Inc. to Host Investor Meetings at Craig-Hallum Alpha Select Conference

AUSTIN, Texas–(BUSINESS WIRE)–Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq: APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today announced that Todd Newton, CEO, and Stefanie Cavanaugh, CFO, will host investor meetings at the 10th Annual Craig-Hallum Alpha Select Conference. The conference will be held Tuesday, November 12, 2019 at the Sheraton Times Square Hotel in New York City.

Investors interested in scheduling a meeting should contact their Craig-Hallum sales representative or Apollo Endosurgery investor relations at mkreps@darrowir.com.

About Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc. is a medical technology company focused on less invasive therapies to treat various gastrointestinal conditions, ranging from gastrointestinal defect repairs to the interventional treatment of obesity. Apollo’s device-based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products are offered in over 80 countries today and include the OverStitch™ Endoscopic Suturing System, the OverStitch Sx™ Endoscopic Suturing System, and the ORBERA® Intragastric Balloon.

Apollo’s common stock is traded on Nasdaq Global Market under the symbol “APEN”. For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.

Contacts

Apollo Endosurgery, Inc.

Stefanie Cavanaugh, 512-279-5100

investor-relations@apolloendo.com

Darrow Associates Investor Relations

Matt Kreps, 214-597-8200

mkreps@darrowir.com